In this article, we discuss the 15 Best Shareholder Activism Law Firms. If you would like to discuss our detailed discussion and analysis of the shareholder activism space as of 2024, you can skip it and go directly to 5 Best Shareholder Activism Law Firms. A shareholder activist is someone who brings about changes within a […]
In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.
Gene-sequencing company Illumina, which was pushed to make changes by Carl Icahn last year, had two additional activist investors in its stock at the end of the fourth quarter, according to new regulatory filings. Keith Meister's Corvex Management disclosed buying Illumina stock during the last three months of 2023 and owning 730,084 shares on Dec. 31. The buying came after the stock price edged lower for most of the year even after investors sided with Icahn's arguments that changes were needed at the company and elected one of his director candidates to Illumina's board.